Genuine Very Large Effects in Trials Rare in Medicine

Very large effects typically seen in small trials and diminish subsequently; seldom address mortality

TUESDAY, Oct. 23 (HealthDay News) -- Large treatment effects are most likely to be found in small studies, with the effect diminishing with additional trials, according to research published in the Oct. 24 issue of the Journal of the American Medical Association.

Tiago V. Pereira, Ph.D., from the German Hospital Oswaldo Cruz in São Paulo, Brazil, and colleagues analyzed the Cochrane Database of Systematic Reviews (CDSR) and separated all binary-outcome forest plots with comparisons of interventions according to whether the first published trial, a subsequent trial, or no trial had a nominally statistically significant (P < 0.05) very large effect (odds ratio, ≥5).

The researchers found that 8,239 (9.7 percent) of the 85,002 forest plots (from 3,082 reviews) had a significant very large effect in the first published trial; 5,158 (6.1 percent) only after the first published trial; and the majority (71,605; 84.2 percent) had no trials with significant very large effects. Nominally significant, very large effects were typically observed in small trials, with a median of 18 events in first trials and 15 events in subsequent trials. Very large effects were less likely to address mortality and were more likely to address laboratory-defined efficacy. Subsequent published trials were just as likely for first trials with and for those without very large effects. In subsequent meta-analysis, 90 and 98 percent of the very large effects observed in first and subsequently published trials, respectively, became smaller. Only one intervention across the whole CDSR had large beneficial effects on mortality with no major concerns about the quality of evidence.

"Genuine very large effects with extensive support from substantial evidence appear to be rare in medicine and large benefits for mortality are almost entirely nonexistent," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events